Screener
Journey Medical Corporation DERM Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Journey Medical Corporation’s 10-Q, filed August 12, 2026.
- Filed
- Aug 12, 2026, 4:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-094948
| Line item | Three-Month Periods Ended / June 30, 2026 | Three-Month Periods Ended / June 30, 2025 | Six-Month Periods Ended / June 30, 2026 | Six-Month Periods Ended / June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product revenue, net | $17,839 | $15,009 | $33,760 | $28,148 |
| Other revenue | 671 | — | 711 | — |
| Total revenue | 18,510 | 15,009 | 34,471 | 28,148 |
| Operating expenses | ||||
| Cost of goods sold – (excluding amortization of acquired intangible assets) | 6,143 | 4,939 | 12,361 | 9,729 |
| Amortization of acquired intangible assets | 969 | 1,064 | 2,095 | 2,129 |
| Research and development | 54 | — | 54 | 39 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Journey Medical Corporation's total revenue?
- Journey Medical Corporation (DERM) reported total revenue of $18.51M in Q2 2026.
- How has Journey Medical Corporation's total revenue changed year-over-year?
- Journey Medical Corporation's total revenue increased by 23.3% year-over-year, from $15.01M to $18.51M.
- What is the long-term trend for Journey Medical Corporation's total revenue?
- Over 4 years (2021 to 2025), Journey Medical Corporation's total revenue has grown at a -0.5% compound annual growth rate (CAGR), from $63.13M to $61.86M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Journey Medical Corporation's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude